Related Experiment Videos
Novel risk factors for atherosclerosis
I J Kullo1, G T Gau, A J Tajik
1Division of Cardiovascular Diseases, Mayo Clinic Rochester, Minn. 55905, USA.
Mayo Clinic Proceedings
|April 13, 2000
Summary
Novel risk factors beyond traditional ones like homocysteine and lipoprotein(a) are crucial for understanding atherosclerosis development and cardiovascular events. Identifying these markers improves prevention and treatment strategies.
Area of Science:
- Cardiovascular Medicine
- Pathophysiology
- Biochemistry
Background:
- Conventional risk factors explain less than half of cardiovascular events.
- Traditional risk factors' impact may vary across ethnic groups.
- Novel risk factors are increasingly implicated in atherosclerosis.
Purpose of the Study:
- To review evidence linking novel risk factors to atherosclerosis.
- To explore the mechanisms and clinical implications of these factors.
- To enhance understanding of atherosclerosis pathogenesis.
Main Methods:
- Literature review of studies on atherosclerosis risk factors.
- Analysis of evidence for novel risk factors' roles.
- Discussion of pathobiology and clinical relevance.
Main Results:
- Novel factors include homocysteine, fibrinogen, lipoprotein(a), and inflammatory markers.
- These factors contribute significantly to atherosclerosis development.
- Understanding these markers aids in risk prediction.
Conclusions:
- Novel risk factors are essential for a comprehensive view of atherosclerosis.
- Further research into these markers can lead to better preventive and therapeutic strategies.
- This knowledge improves insight into cardiovascular disease.